Premium
Aripiprazole, a partial dopamine agonist to improve adolescent anorexia nervosa—A case series
Author(s) -
Frank Guido K.W.
Publication year - 2016
Publication title -
international journal of eating disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.785
H-Index - 138
eISSN - 1098-108X
pISSN - 0276-3478
DOI - 10.1002/eat.22485
Subject(s) - anorexia nervosa , psychology , aripiprazole , partial agonist , dopamine agonist , dopamine , agonist , psychiatry , eating disorders , extinction (optical mineralogy) , psychotherapist , bulimia nervosa , schizophrenia (object oriented programming) , medicine , neuroscience , dopaminergic , receptor , paleontology , biology
Anorexia nervosa (AN) is a severe and complex psychiatric disorder and no medication has been approved for its treatment. This case series in youth with severe, recurrent AN supports the hypothesis that dopamine receptor agonists could be helpful in supporting fear extinction during eating disorder focused psychotherapy and therefore support recovery from AN. © 2015 Wiley Periodicals, Inc. (Int J Eat Disord 2016; 49:529–533).